Revenue

A major partnership brings high-tech, locally grown organic herbs to Mid-Atlantic shelves, aiming to slash food miles and redefine retail freshness.

A new partnership between DoControl and Sentra promises to turn data insights into automated security, closing a critical gap in SaaS data protection.

A new pharma-tech alliance aims to leverage quantum computing and AI to create safer opioids, but the non-binding deal faces significant hurdles.

The custom apparel leader partners with a top agency to expand its reach into sports, entertainment, and universities. Here's what the deal means for fans.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

Responding to social media demand, Whataburger brings back the Monterey Melt and Chicken Fajita Taco, while introducing a new value-focused wrap.

Newly public AI firm Fusemachines unveils an ambitious 2026 growth plan, but faces significant financial hurdles and deep investor skepticism.

Facing declining revenue, Cardlytics brings back former CFO David Evans, who led its 2018 IPO, in a strategic bet on experience for its next chapter.

Leveraging a fleet of vintage F-104 jets, Starfighters Space raises $40M and goes public, aiming to disrupt the small satellite launch market.

A new alliance led by engineering giant AtkinsRéalis will deliver the Midlands Rail Hub, a project promising vast economic growth and 300 extra trains daily.

Revelstoke Mountain Resort unveils new luxury homes, fueling its transformation into a year-round hub amid a local housing crunch and soaring demand.

Vancouver-based TRUBAR agrees to a C$201M buyout by Turkish food conglomerate ETİ Gıda, marking a major move in the booming plant-based snack market.

A breakthrough genetic test helps prostate cancer patients avoid severe side effects from radiation while saving the healthcare system millions of dollars.

With trial data showing an average 23% body weight loss, Novo Nordisk's new combination drug CagriSema could usher in a powerful new era for medicine.

Pending home sales fell nearly 6% as high mortgage rates and economic jitters sideline both buyers and sellers, creating a deeply uneven national market.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

IIM Udaipur is the first IIM to offer a two-week campus immersion, giving MBA aspirants a unique trial run of B-school life before they commit.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

Struggling Inno Holdings rolls the dice with a massive reverse stock split to avoid delisting, but grim financials and a brutal market reaction raise alarms.

After a challenging year marked by a mine fire and merger pains, Core Natural Resources is back online, signaling a major financial turnaround for 2026.